Ftse Mib
33.758,43
-1,27%
DAX
19.189,19
-0,16%
S&P 500
5.893,62
0,39%
NASDAQ
18.791,81
0,60%
Bitcoin
91.350,99
0,88%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aura Biosciences Inc (AURA) Aura Biosciences Inc (AURA) Notizie

Aura Biosciences Inc

AURA
9,15
-0,32 (-3,38%)
19 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/11/202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202401:32EDGAR2Form 144 - Report of proposed sale of securities
14/11/202423:50EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:10EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEAura Biosciences Reports Third Quarter 2024 Financial..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
30/10/202401:38EDGAR2Form 144 - Report of proposed sale of securities
30/10/202401:33EDGAR2Form 144 - Report of proposed sale of securities
30/10/202401:33EDGAR2Form 144 - Report of proposed sale of securities
30/10/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202401:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/10/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:21EDGAR2Form 144 - Report of proposed sale of securities
18/10/202422:21EDGAR2Form 144 - Report of proposed sale of securities
17/10/202423:10EDGAR2Form 8-K - Current report
17/10/202422:05GLOBEMultiple Clinical Complete Responses Demonstrated Following..
17/10/202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:22EDGAR2Form 144 - Report of proposed sale of securities
01/10/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:05EDGAR2Form 8-K - Current report
12/9/202412:50EDGAR2Form 8-K - Current report
12/9/202412:30GLOBEAura Biosciences Reports Positive Phase 2 End of Study..
03/9/202422:05GLOBEAura Biosciences to Host a Urologic Oncology Investor Event..
28/8/202422:05GLOBEAura Biosciences to Participate in Upcoming Investor..
26/8/202422:05GLOBEAura Biosciences Announces the Presentation of Phase 2 End..
08/8/202413:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:05EDGAR2Form 8-K - Current report
08/8/202413:00GLOBEAura Biosciences Reports Second Quarter 2024 Financial..
14/6/202422:42EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/6/202422:37EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
04/6/202423:07EDGAR2Form 8-K - Current report
30/5/202422:05GLOBEAura Biosciences to Participate in the Jefferies Global..
23/5/202414:00GLOBEAura Biosciences to Host Virtual KOL Event “Pioneering a New..
09/5/202413:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:05EDGAR2Form 8-K - Current report
09/5/202413:00GLOBEAura Biosciences Reports First Quarter 2024 Financial..
08/5/202413:00GLOBEAura Biosciences to Participate in Upcoming Investor..
27/3/202412:00BWAura Biosciences Reports Fourth Quarter and Full Year 2023..
04/3/202423:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202413:00BWAura Biosciences to Participate in Upcoming Investor..
23/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
02/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:01EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 9,51 Min: 9,03 Max: 9,785
Chiusura: 9,47

La tua Cronologia

NASDAQ
AURA
Aura Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network